Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
HMN-176 is an anticancer agent and active metabolite of the prodrug HMN-214 (Item No. 26210).1 It is cytotoxic against a panel of cancer cell lines with a mean IC50 value of 112 nM, as well as P388 leukemia cells that are resistant to the DNA-crosslinking agent cisplatin (Item No. 13119), anthracycline antitumor antibiotic doxorubicin (Item No. 15007), or antimitotic vincristine (Item No. 11764) (IC50s = 143, 557, and 265 nM, respectively). HMN-176 (3 µM) induces cell cycle arrest at the G2/M phase in HeLa cervical cancer cells.
WARNING This product is not for human or veterinary use.
1. In vivo antitumor activity of a novel sulfonamide, HMN-